Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
9.02
-0.24 (-2.59%)
At close: Dec 30, 2025, 4:00 PM EST
9.00
-0.02 (-0.22%)
Pre-market: Dec 31, 2025, 9:00 AM EST
Tilray Brands Revenue
Tilray Brands had revenue of $209.50M in the quarter ending August 31, 2025, with 4.73% growth. This brings the company's revenue in the last twelve months to $830.77M, up 2.31% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$830.77M
Revenue Growth
+2.31%
P/S Ratio
1.02
Revenue / Employee
$292,317
Employees
2,842
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 302.60M | 143.77% |
| Dec 31, 2020 | 210.48M | -194.84M | -48.07% |
| May 31, 2020 | 405.33M | 27.87M | 7.38% |
| Dec 31, 2019 | 377.46M | 198.16M | 110.52% |
| Jun 30, 2019 | 179.30M | 136.17M | 315.73% |
| Dec 31, 2018 | 43.13M | - | - |
| Jun 30, 2018 | 43.13M | 22.59M | 110.00% |
| Dec 31, 2017 | 20.54M | -25.57M | -55.45% |
| Jun 30, 2017 | 46.10M | 33.46M | 264.62% |
| Dec 31, 2016 | 12.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TLRY News
- 1 day ago - Trump Is Warming to Cannabis, but Investors Aren't Impressed - WSJ
- 6 days ago - Marijuana Stocks To Watch After The Holidays - MarijuanaStocks
- 7 days ago - Is Tilray Stock's 25% Drop An Opportunity Or Trap? - Forbes
- 9 days ago - Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026 - GlobeNewsWire
- 11 days ago - Inside the dealmaking that pushed Trump to reclassify pot, expand access - CNBC
- 11 days ago - After Trump's move to reclassify cannabis, here's what Wall Street is thinking - Market Watch
- 11 days ago - Trump just legalized marijuana nationwide — here's why potheads are rejoicing - New York Post
- 12 days ago - Why US banks are still wary of cannabis despite Trump's policy shift - Invezz